Product Information
GABAPENTIN 300 MG CAPSULE is a generic product labeled by Actavis Pharma, Inc., priced at $0.0324 per EA under NDC 45963055650. Its NADAC has been published 629 times since Jun 11, 2014.
Strength
300 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
45963055650
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA075350On Market Since
4/3/2014
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 300 MG CAPSULE has been published 629 times since Jun 11, 2014, and over the history we have for it it has declined 43.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0324 per EA |
|---|---|
| All-time high | $0.0601 (Jan 16, 2019) |
| All-time low | $0.0313 (Nov 20, 2024) |
| 52-week high | $0.0361 |
| 52-week low | $0.0324 |
| Median price | $0.0448 |
| Average price | $0.0454 |
| Largest weekly change | -17.0% (Nov 20, 2024) |
| Weeks tracked | 629 |
| Tracking since | Jun 11, 2014 |
Generic Alternatives
The matcher finds 17 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GABAPENTIN 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 300 MG CAPSULE, manufactured by Actavis Pharma, Inc., is $0.0324 per EA (NDC 45963055650), effective Jun 24, 2026.
How has the price of GABAPENTIN 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 300 MG CAPSULE has declined 43.8%. It has been tracked across 629 weekly CMS publications since Jun 11, 2014.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 300 MG CAPSULE?
Since Jun 11, 2014, the NADAC for GABAPENTIN 300 MG CAPSULE has ranged from a low of $0.0313 (Nov 20, 2024) to a high of $0.0601 (Jan 16, 2019), with a median of $0.0448 per EA.
Are there cheaper alternatives to GABAPENTIN 300 MG CAPSULE?
17 NADAC-published products share the same active ingredient, strength, and dosage form as GABAPENTIN 300 MG CAPSULE, but none are currently priced below it.
Who manufactures GABAPENTIN 300 MG CAPSULE?
GABAPENTIN 300 MG CAPSULE (NDC 45963055650) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification